Few urologists follow peri-op thromboprophylaxis guidelines

August 16, 2013
Few urologists follow peri-op thromboprophylaxis guidelines
Among American Urological Association members, self-reported adherence to the Best Practice Statement on the use of thromboprophylaxis in patients undergoing urological procedures is low, according to research published in the September issue of The Journal of Urology.

(HealthDay)—Among American Urological Association (AUA) members, self-reported adherence to the Best Practice Statement on the use of thromboprophylaxis in patients undergoing urological procedures is low, according to research published in the September issue of The Journal of Urology.

Steve Sterious, M.D., of the Temple University School of Medicine in Philadelphia, and colleagues sent an electronic survey to 10,966 AUA members to assess adherence to the AUA Best Practice Statement on the use of thromboprophylaxis for urological procedures.

The researchers found that, among 1,210 survey responses, the largest group of respondents was urological oncologists and/or laparoscopic/robotic specialists (26.0 percent); this group reported greater use of thromboprophylaxis (odds ratio [OR], 1.3) than non-urological and/or laparoscopic/robotic specialists. About half of the respondents were aware of the guidelines, and familiarity with the Best Practice Statement was associated with a higher likelihood of use of thromboprophylaxis (OR, 1.4). Urologists who recently completed residency training (graduating after the year 2000) were significantly more likely to use thromboprophylaxis in high- undergoing radical cystectomy (79.2 percent) than were earlier graduates (63.4 percent).

"Self-reported adherence to AUA Best Practice Statement was low, even in high risk cases with clear AUA Best Practice Statement recommendations such as radical cystectomy," the authors write. "These data identify opportunities for quality improvement in patients undergoing major urological surgery."

One study author disclosed financial ties to pharmaceutical companies.

Explore further: Mayo Clinic finds surgeon caseload, practice setting affect treatment of small kidney tumors

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Similar oncologic efficacy for robotic, open cystectomy

December 21, 2012

(HealthDay)—For patients with bladder cancer undergoing radical cystectomy, a robotic approach seems to have the same oncologic efficacy as an open approach and demonstrates potential perioperative benefits, according to ...

Men say they want prostate cancer test, despite risks

July 9, 2013

A survey of men age 40 to 74 found that 54 percent said that they would still opt for a popular prostate cancer screening test despite recent recommendations that the test not be performed, finds a new study in American Journal ...

Quality-of-life tools underused by prostate cancer docs

July 19, 2013

(HealthDay)—More than half of radiation oncologists and urologists in the United States use prostate cancer nomograms, but only about one-quarter use quality-of-life and life-expectancy prediction instruments, according ...

Recommended for you

Cellphone data can track infectious diseases

August 20, 2015

Tracking mobile phone data is often associated with privacy issues, but these vast datasets could be the key to understanding how infectious diseases are spread seasonally, according to a study published in the Proceedings ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.